Banner: Racquel - BENLYSTA Patient, racquel-benlysta-patient

“Sorry, Lupus.

I’m focusing on me today.”

Racquel Real patient compensated by GSK

In a clinical study in Black patients with lupus, a reduction in disease activity was seen but was not statistically significant. Ask your doctor about BENLYSTA.

Why BENLYSTA?

Whether you have lupus or lupus nephritis, adding BENLYSTA to your treatment plan may help. 

In three clinical studies of adult patients with active lupuslupus: Lupus, also referred to as systemic lupus erythematosus (SLE): A chronic disorder in which the immune system attacks the body; this can lead to inflammation in many organ systems, including joints, skin, heart, lungs, and kidneys., BENLYSTA*:

icon-silhouette

Significantly reduced lupus disease activity

mainly related to improvements in the immune system, muscles, joints, and skin.

icon-symptoms

Significantly reduced risk of severe flaresA measurable increase in disease activity in one or more organ systems. A severe flare will also involve new or worsening clinical signs and symptoms and/or laboratory measurements. There are different tools to assess disease activity.

in two of the three studies.

icon-symptoms

Reduced steroid dose by 25% or more

(to a daily dose of 7.5 mg or less) during Weeks 40-52, in patients receiving 7.5 mg or higher daily doses of steroid at the start of the studies.†‡

In a 2-year clinical study of adult patients with active lupus nephritislupus nephritis: Lupus nephritis is a possible complication of lupus that occurs when lupus autoantibodies affect structures in the kidneys that filter out waste. This causes kidney inflammation and may lead to blood in the urine, protein in the urine, high blood pressure, impaired kidney function, or even kidney failure., BENLYSTA:

icon-symptoms

Significantly reduced kidney disease activity

with maintained kidney function, reduced protein in the urine, and reduced need for rescue medicines.†§

icon-silhouette

Significantly reduced risk of kidney worsening

during the study by almost 50%.

Results may vary.

 

* Studies used in the FDA approval of BENLYSTA

Compared to other lupus medicines alone

A reduction of steroid dose was seen but was not statistically significant.

§ Such as steroids greater than 10 mg/day

 

Ask your doctor if BENLYSTA is right for you.

Hear from our patients

When considering a new treatment, it’s important to hear from others like you. Find out how adding BENLYSTA has helped Morgan and Stephanie manage their lupus.

 

icon-stephanie

Stephanie, Working Mom

Diagnosed in 2011 and started BENLYSTA in 2017

I think of lupus as a speed bump and not a stop sign. It has taught me how to maneuver and manage my stress levels so that I can still live my life.

Stephanie Real patient compensated by GSK

I think of lupus as a speed bump and not a stop sign. It has taught me how to maneuver and manage my stress levels so that I can still live my life.

Stephanie Real patient compensated by GSK

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active, systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines.
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active, systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines.
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. Please see complete Prescribing Information, including Medication Guide, at BENLYSTA.com.

NARRATOR:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. Please see complete Prescribing Information, including Medication Guide, at BENLYSTA.com.
Remember to watch the complete video to see additional safety information.

STEPHANIE:
Hi, I'm Stephanie. I'm 32 and I live in Texas. This is my experience.

ON-SCREEN TEXT:
Real patient compensated by GSK.

ON-SCREEN TEXT:
In a clinical study in Black patients with lupus, a reduction in disease activity was seen but was not statistically significant. Ask your doctor about BENLYSTA.

STEPHANIE:
I grew up dancing with my sister and I just love to move around and be active. When I was in college, I could tell something was wrong. My joints were hurting and I wasn't able to move the way I used to move.

STEPHANIE:
I was diagnosed in 2011 when I was 23 with systemic lupus. It was a stressful time because I was in my last year of grad school. I was just about to graduate. Infections all the time. It was one thing after another.

STEPHANIE:
My mom told me to go see a rheumatologist because my primary doctor wasn't able to diagnose the problem. The rheumatologist did a series of tests and abruptly one day told me just matter of fact, "You have lupus."

STEPHANIE:
I knew what lupus was before the diagnosis, but I am the first person in my family to have it. I was terrified and just confused. I felt really alone.

STEPHANIE:
I was diagnosed on a Friday and I remember my mom dropped everything she was doing and drove four hours to me at grad school. I'll never forget it.

STEPHANIE:
So I have a positive outlook on life. Often when people meet me, they have no idea I have lupus.

STEPHANIE:
So I'm a busy mom. I'm active, I'm always doing something, and I don't want to be reminded that I have lupus all the time.

STEPHANIE:
I have three tips that help me maintain my lupus. I maintain my stress, delegate tasks, and definitely stay organized.

ON-SCREEN TEXT:
HOW STEPHANIE DOES IT
1. Maintain my stress
2. Delegate tasks
3. Stay organized

STEPHANIE:
My life is super busy. I’m a wife and a mom, and I work full time with a lot of other activities.

STEPHANIE:
I have an amazing support system. My husband, my mom and dad and my sister are always there to support me.

STEPHANIE:
I try to get ahead of it and ask for help rather than try to do it all on my own because the moment I get stressed, that's when it pushes me over the edge.

STEPHANIE:
BENLYSTA helps, too. My doctor brought up BENLYSTA a few times, but I wasn't interested because I thought it was only available in an infusion. Scheduling monthly appointments wasn't for me. So I kept saying no. My doctor told me about the subcutaneous injection, and at that point, I was interested in learning more.

ON-SCREEN TEXT:
This is Stephanie’s experience. Yours may vary

ON-SCREEN TEXT:
BENLYSTA is an add-on therapy. Results may vary.

STEPHANIE:
What I love about it is being able to use it whenever I need to and how easy it is to access it at home. I do my injection every Friday because that's the day that works best for me. What I love about it is just the versatility of it, being able to grab it and keep going on with my day.

STEPHANIE:
I always have my phone in my hand, so I set two reminders, one weekly reminder to take it out of the refrigerator 30 minutes before my injection, and another reminder to actually take the injection. I do the reminders because I'm so busy and I love that BENLYSTA allows me to live my life and just schedule a quick reminder in my day. It doesn't slow me down.

ON-SCREEN TEXT:
STEPHANIE’S TIPS
1
Weekly Reminder 1: Take your dose out of the fridge
2
Weekly Reminder 2: Take your dose

STEPHANIE:
I think of lupus as a speed bump and not a stop sign. That's the best way for me to describe it because it didn't stop my life. It has taught me how to maneuver and manage my stress levels so that I can still live my life.

STEPHANIE:
If I could tell lupus one thing, I would say thank you because, you thought you would stop me, but really you were just a speed bump to slow me down. You taught me how to manage my time, you taught me how to prioritize myself, and you taught me to remember that I'm the most important thing. So instead of being mad at lupus, I'm like, thanks for coming. You've taught me a lesson and you can stay, but now you’re along for my ride. “Sorry, Lupus. You don't get to run this show.”

NARRATOR:
Ready to say, "Sorry, Lupus”? Whether you have lupus or lupus nephritis, adding BENLYSTA may help. Financial assistance is available. Ask your doctor about BENLYSTA.

ON-SCREEN TEXT:
ASK YOUR DOCTOR ABOUT BENLYSTA

ON-SCREEN TEXT:
For financial assistance information, visit the Savings & Support tab of BENLYSTA.com.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

NARRATOR:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.
Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.
Before receiving BENLYSTA also discuss with your healthcare provider if you:
think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
have or have had mental health problems such as depression or thoughts of suicide.
have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
are allergic to other medicines.
are receiving other biologic medicines or monoclonal antibodies.
have or have had any type of cancer.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least four months after the final dose of BENLYSTA. Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.
Possible side effects of BENLYSTA
Progressive multifocal leukoencephalopathy (PML).
PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

  • Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
  • Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
  • Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.

Before receiving BENLYSTA also discuss with your healthcare provider if you:

  • think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
  • have or have had mental health problems such as depression or thoughts of suicide.
  • have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
  • are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
  • are allergic to other medicines.
  • are receiving other biologic medicines or monoclonal antibodies.
  • have or have had any type of cancer.
  • have any other medical conditions.
  • are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.
    Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
  • become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
  • are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.

Possible side effects of BENLYSTA

  • Progressive multifocal leukoencephalopathy (PML). PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
  • Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.
©2021 GSK or licensor.
BELVID200019 March 2021
Produced in USA.

Real Patient Experiences with BENLYSTA SC

Switching from IV to SC

Setting up Co-pay Support

Morgan’s Tips for Working with Your Speciality Pharmacy

What to Expect in Your Package

Important Safety Information

Switching from IV to SC

Setting up Co-pay Support

Morgan’s Tips for Working with Your Speciality Pharmacy

What to Expect in Your Package

Important Safety Information

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines.

NARRATOR:
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
What is BENLYSTA?
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

NARRATOR:
Please click the Important Safety Information tab to the left to watch or hear the Important Safety Information about BENLYSTA.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.
Please click the Important Safety Information tab to left to watch or hear the Important Safety Information about BENLYSTA.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
What I like about BENLYSTA SC

STEPHANIE:
Hi, I'm Stephanie, I'm 32 and I live in Texas. I started BENLYSTA in 2017. This is my experience. My doctor brought up BENLYSTA a few times, but I wasn't interested because I thought it was only available via infusion. Knowing that I had to do a monthly infusion appointment, I knew it would slow me down. Finally, my doctor said that there was a subcutaneous injection that I could use at home, and that's why I finally agreed. My doctor showed me how to do the injection and what works for me is I can schedule it on my life, on my terms. Being able to grab it and keep going with my day works for me. I also liked that it comes directly to my house because it comes from the specialty pharmacy.

ON-SCREEN TEXT:
Real patient compensated by GSK. In a clinical study in Black patients with lupus, a reduction in disease activity was seen but was not statistically significant. Ask your doctor about BENLYSTA.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Getting started with a Specialty Pharmacy

STEPHANIE:
Getting BENLYSTA from a specialty pharmacy is different than going to a neighborhood pharmacy to pick your medication up. First, my doctor's office works with my insurance company to get approval.

ON-SCREEN TEXT:
SPECIALTY PHARMACY
Pharmacies that dispense particular medications for certain conditions.
Real patient compensated by GSK.

STEPHANIE:
Then once it was approved, the specialty pharmacy called me. They needed to speak with me so they could ship my BENLYSTA. They collected my co-pay and confirmed my shipment.

STEPHANIE:
I didn't recognize the number the first time so I had to call them back. After that I put the number in my phone so that I would answer when they called. I don't like to answer calls from numbers that I don't know.

ON-SCREEN TEXT:
STEPHANIE’S TIPS
1. Answer your phone when the specialty pharmacy calls.
2. Be sure to return their calls.
3. Add them as a contact in your phone.

STEPHANIE:
I had a lot of questions, things like, what do I need to do to get future refills? When should I expect to get my BENLYSTA? I also asked if there was additional support to help me pay for BENLYSTA, and that's how I learned about the BENLYSTA Co-pay Program. You can sign up online or BENLYSTA Cares can help. The co-pay program gave me a virtual debit card to use with my specialty pharmacy.

NARRATOR:
To participate in the BENLYSTA Co-pay Program, work with your doctor to enroll in BENLYSTA Gateway or go to BENLYSTACopayProgram.com to register and see if you're eligible. Renewal is once a year.

ON-SCREEN TEXT:
The BENLYSTA Co-pay Program helps eligible approved patients with their out-of-pocket costs for BENLYSTA up to $15,000 for 12 months.
If approved, you could pay as little as $0 for BENLYSTA.
For full terms and conditions, visit BENLYSTACopayProgram.com

STEPHANIE:
If you need help, you can always call BENLYSTA Cares. They can help you figure out all kinds of things and put you in touch with BENLYSTA Gateway for co-pay assistance and help with understanding your insurance.

ON-SCREEN TEXT:
BENLYSTA Cares is here to support you with:
• navigating insurance coverage
• co-pay assistance
• access to nurse/telehealth resources
• on-demand self-injection support
• answers, information, tips, and tools
Nurses from BENLYSTA Cares do not give medical advice, and will direct you to your healthcare provider for any disease-, treatment-, or referral-related questions.

STEPHANIE:
To get my BENLYSTA I have two options. One, they can ship it to my local drug store; two, they can send it where it's convenient for me. I have it sent directly to my house. You can have it sent to your office as another option. They make it convenient for me and everything is packed with ice packs.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Stephanie’s tips for working with your Specialty Pharmacy

STEPHANIE:
Here are my tips to work with your specialty pharmacy. Most pharmacies offer programs to help you remember to fill your prescription. They may even call you and text you to remind you, “Hey, it's time to refill your prescription." I called the specialty pharmacy to see if they had autofill option. I also put a reminder in my phone, a monthly reminder to say, "Hey, it's time to order it.” Since I'm registered for the co-pay savings program, I made sure to give the specialty pharmacy my virtual co-pay debit card information at my first fill. Since I do autofill, they could take care of that part too. I left a note with the specialty pharmacy and the shipping company to let them know to leave the medication at the door. One time the shipping company took it with them because I wasn't there to sign for it. It works because I have a porch for them to leave it. The specialty pharmacy I use is very proactive. If I call them and tell them when I need my dose, they make sure that it's there. When I was behind on ordering it, they overnighted it. They do a really great job of understanding the importance of these type of medications.

ON-SCREEN TEXT:
SPECIALTY PHARMACY TIPS
1. Use autofill
2. Share your preferences
Make sure to follow all instructions provided by BENLYSTA Gateway so that the Specialty Pharmacy can process your virtual co-pay debit card.
3. Let them help you
BENLYSTA may be stored outside of the refrigerator up to 86°F for up to 12 hours if protected from sunlight.

STEPHANIE:
When I'm ready to do my injection, my autoinjector is here at the house, so I'm ready to pull it out of the fridge. I like that it's easy to deal with. I schedule my injections. I do them every Friday because that's the day that works for me.

STEPHANIE:
I live with the phone in my hand, so I might as well put it to work. This is what I do to remember when I'm running on all cylinders and I'm super busy. Maybe this would work for you too. I put two weekly reminders in my phone. One to take the dose out of the fridge, 30 minutes before, and another reminder to take the dose.

ON-SCREEN TEXT:
STEPHANIE’S TIPS
1
Weekly Reminder 1: Take your dose out of the fridge.
2
Weekly Reminder 2. Take your dose.

STEPHANIE:
I'm definitely glad there's a specialty pharmacy handling getting the BENLYSTA to me. It's different than picking up a prescription at a pharmacy, but I like that it’s at my door when I need it.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. BENLYSTA IV is approved in children aged 5 years and older with SLE on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

NARRATOR:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. 
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.
Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.
Before receiving BENLYSTA also discuss with your healthcare provider if you:
think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
have or have had mental health problems such as depression or thoughts of suicide.
have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
are allergic to other medicines.
are receiving other biologic medicines or monoclonal antibodies.
have or have had any type of cancer.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least four months after the final dose of BENLYSTA.
Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.
Possible side effects of BENLYSTA
Progressive multifocal leukoencephalopathy (PML).
PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. 
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

  • Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
  • Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
  • Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.

Before receiving BENLYSTA also discuss with your healthcare provider if you:

  • think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
  • have or have had mental health problems such as depression or thoughts of suicide.
  • have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
  • are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
  • are allergic to other medicines.
  • are receiving other biologic medicines or monoclonal antibodies.
  • have or have had any type of cancer.
  • have any other medical conditions.
  • are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least four months after the final dose of BENLYSTA.
    Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
  • become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
  • are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.

Possible side effects of BENLYSTA

  • Progressive multifocal leukoencephalopathy (PML). PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
  • Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.
©2021 GSK or licensor.
BELVID210032 June 2021
Produced in USA.

icon-morgan

Morgan, Business Owner

Diagnosed in 2002 and started BENLYSTA in 2011

If I could tell lupus off, I’d say leave me alone: I’m going to push forward. Sorry, lupus not today.

Morgan Real patient compensated by GSK

If I could tell lupus off, I’d say leave me alone: I’m going to push forward. Sorry, lupus not today.

Morgan Real patient compensated by GSK

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines.
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. Please see complete Prescribing Information, including Medication Guide, at BENLYSTA.com.

NARRATOR:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. Please see complete Prescribing Information, including Medication Guide, at BENLYSTA.com.
Remember to watch the complete video to see additional safety information.

MORGAN:
Hey. I am Morgan. I am 32 years old, and I am from South Carolina. I'm married to a great guy named Tim. On my days off, I love to be outside, near the water, maybe at the beach, and I do enjoy fishing. This is my experience.

ON-SCREEN TEXT:
Real patient compensated by GSK.

MORGAN:
When I was 10 or 11, I knew it wasn't normal that I was experiencing joint pain, weakness, muscle fatigue, trouble opening certain, you know, a bottle of water or a can of soda. For me, it was very tough growing up like that because there are so many things that go into it, and not being able to enjoy some of the simple things in life.

MORGAN:
It took a long time to get my lupus diagnosis. There is no specific test that shows that you have lupus. When the doctor told me that I had SLE lupus, it was relief. It was knowing that this wasn't in my head. It wasn't imaginary.

MORGAN:
Looking back, I felt like it was kind of like a caged animal. It was really, really tough. Lupus isn't the main thing that defines me. I work a full-time job, I live a wonderful life with my husband, and truly just enjoy it. Having a good attitude and helping other people I think has made me the person I am today. I try to help people understand what it's like having lupus. I would tell them to, be an advocate for yourself, ask those hard questions, and really do your research. This is your life. This is your journey with lupus. Find a doctor that you can be comfortable with and that you can partner with; somebody that you can have those conversations and- and really feel like they are your best advocate also.

ON-SCREEN TEXT:
Lupus isn’t the main thing that defines me
Be an advocate for yourself
Find a doctor you are comfortable with

MORGAN:
When I started with my doctor, we tried a lot of combinations of medications to treat my lupus. My symptoms were not controlled, so my doctor suggested that we start BENLYSTA. At first, I was very scared trying a biologic medication. I didn't know what BENLYSTA was and what it meant. I didn't know what it would do for the rest of my life. I had to ask all those questions. My doctor gave me the information that we were looking for and was able to kind of help me understand.

ON-SCREEN TEXT:
This is Morgan’s experience. Yours may vary.

ON-SCREEN TEXT:
BENLYSTA is an add-on therapy.

ON-SCREEN TEXT:
A biologic therapy is a treatment derived from living tissues or cells.

MORGAN:
I decided to give BENLYSTA a try, and I started out on the IV formulation. The infusion center was a little intimidating. I did what I always do. I asked a lot of questions and definitely felt a little bit better about the situation.

ON-SCREEN TEXT:
IV formulation = intravenous formulation

MORGAN:
After a while, going and receiving my BENLYSTA was just routine. It was normal. Taking that afternoon off one time a month was tough. I work 40 to 50 hours a week, and not having that flexibility was tough. So, I spoke with my doctor and we decided that I should try the self-injection. My doctor showed me how to do the auto-injection, and I remember the first time that I did it, I was nervous and scared. But after each time, I definitely grew in confidence, and now I feel very comfortable doing them. I like the convenience of a self-injection. I can live my life my way, and I don't have to schedule my life around my infusions.

ON-SCREEN TEXT:
Morgan was trained by her doctor on how to use the autoinjector.

ON-SCREEN TEXT:
Self-injection works at home for Morgan’s life

MORGAN:
Without lupus, I really don't know the type of person I would be. I'm the type of person that rescues dogs and flea-infested cats, and old birds. And that's the type of person that lupus has made me. But if I could tell lupus off, I'd say, "Leave me alone. I'm going to push forward. Sorry, lupus. Not today."

NARRATOR:
Ready to say, "Sorry, Lupus"? Whether you have lupus or lupus nephritis, adding BENLYSTA may help. Financial assistance is available. Ask your doctor about BENLYSTA.

ON-SCREEN TEXT:
ASK YOUR DOCTOR ABOUT BENLYSTA

ON-SCREEN TEXT:
For financial assistance information, visit the Savings & Support tab of BENLYSTA.com.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

NARRATOR:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.
Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.
Before receiving BENLYSTA also discuss with your healthcare provider if you:
think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
have or have had mental health problems such as depression or thoughts of suicide.
have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
are allergic to other medicines.
are receiving other biologic medicines or monoclonal antibodies.
have or have had any type of cancer.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least four months after the final dose of BENLYSTA. Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.
Possible side effects of BENLYSTA
Progressive multifocal leukoencephalopathy (PML).
PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

  • Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
  • Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
  • Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.

Before receiving BENLYSTA also discuss with your healthcare provider if you:

  • think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
  • have or have had mental health problems such as depression or thoughts of suicide.
  • have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
  • are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
  • are allergic to other medicines.
  • are receiving other biologic medicines or monoclonal antibodies.
  • have or have had any type of cancer.
  • have any other medical conditions.
  • are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.

Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.

  • become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
  • are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.

Possible side effects of BENLYSTA

  • Progressive multifocal leukoencephalopathy (PML). PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
  • Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.
©2021 GSK or licensor.
BELVID200018 March 2021
Produced in USA.

Real Patient Experiences with BENLYSTA SC

Switching from IV to SC

Setting up Co-pay Support

Morgan’s Tips for Working with Your Speciality Pharmacy

What to Expect in Your Package

Important Safety Information

Switching from IV to SC

Setting up Co-pay Support

Morgan’s Tips for Working with Your Speciality Pharmacy

What to Expect in Your Package

Important Safety Information

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines.

NARRATOR:
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
What is BENLYSTA?
It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

NARRATOR:
Please click the Important Safety Information tab to left to watch or hear the Important Safety Information about BENLYSTA.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA.
Please click the Important Safety Information tab to left to watch or hear the Important Safety Information about BENLYSTA.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Switching from IV to SC

MORGAN:
My name is Morgan. I'm 32 years old, and I live in South Carolina, and this is my experience. When I started with my doctor, we tried a lot of combinations of medications to treat and manage my lupus. My symptoms were not controlled, so that's when my doctor suggested that we try adding BENLYSTA. I started off with the IV formulation but I was working 40 to 50 hours per week. It was becoming hard to get that afternoon off each month, and so having that flexibility was what I really was going for.

ON-SCREEN TEXT:
Real patient compensated by GSK.

MORGAN:
I used to have to plan my scheduled infusions, so I talked with my doctor and we decided we would try the self-injection.

ON-SCREEN TEXT:
Morgan’s doctor’s office trained her on how to self-inject.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Setting up Co-pay Support

MORGAN:
Since I was already taking BENLYSTA IV, I was already enrolled in the BENLYSTA Co-pay Program. My co-pay benefits continued when I switched to the BENLYSTA autoinjector.

ON-SCREEN TEXT:
Real patient compensated by GSK.

NARRATOR:
To participate in BENLYSTA Co-pay Program, work with your doctor to enroll in BENLYSTA Gateway or go to BENLYSTACopayProgram.com to register and see if you're eligible. Renewal is once a year.

ON-SCREEN TEXT:
The BENLYSTA Co-pay Program helps eligible approved patients with their out-of-pocket costs for BENLYSTA up to $15,000 for 12 months.
If approved, you could pay as little as $0 for BENLYSTA.
For full terms and conditions, visit BENLYSTACopayProgram.com

MORGAN:
My doctor's office let the BENLYSTA Gateway know about the change to my prescription and got me connected to the specialty pharmacy. This was my experience with BENLYSTA Gateway, so be sure to reach out to them to let them know about your prescription change. BENLYSTA Gateway also told my doctor's office about my new insurance since I had different coverage previously. Gateway can help you understand this as well.

ON-SCREEN TEXT:
SPECIALTY PHARMACY
Pharmacies that dispense particular medications for certain conditions.

MORGAN:
While this was happening, I talked to BENLYSTA Gateway too, because they had called me. They helped me set up my co-pay virtual debit card with the specialty pharmacy.

ON-SCREEN TEXT:
MORGAN’S TIPS
1. Tell Gateway about prescription change.
2. Answer the call from Gateway.
3. Check mail for virtual debit card info.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Morgan’s tips for working with your Specialty Pharmacy

MORGAN:
The specialty pharmacy will call you to help arrange the delivery of your autoinjector. Watch for a call from a number you may not recognize.

ON-SCREEN TEXT:
Real patient compensated by GSK.

MORGAN:
Make sure to return their calls because they cannot ship your BENLYSTA without speaking to you first. You might want to add that number to your phone because they'll call you each month to set up your shipment and your co-pay.

ON-SCREEN TEXT:
MORGAN’S TIPS
1. Answer your phone when the specialty pharmacy calls.
2. Be sure to return their calls.
3. Add them as a contact in your phone.

MORGAN:
For renewals, they actually call me about 30 days ahead.

MORGAN:
The specialty pharmacy will send your BENLYSTA autoinjector to where it's convenient for you.

ON-SCREEN TEXT:
MORGAN’S TIPS
Get your BENLYSTA shipped to your home or office, wherever it is convenient for you.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
What to expect in your package

MORGAN:
So, when you open it up, the information will be in there about what's in the box, and then information about BENLYSTA and the drug facts. If you're getting this shipment for the first time, you'll also get a kit to help with your first injection.

ON-SCREEN TEXT:
Real patient compensated by GSK. Injection training kit is subject to availability.

ON-SCREEN TEXT:
After being trained by a healthcare provider, you can self-inject BENLYSTA from the comfort of your own home with a once-weekly subcutaneous injection.

MORGAN:
It was nice having the BENLYSTA Cares nurses there available to walk me through the process over the phone, if I needed them. It's layered with ice packs so it's shipped refrigerated. I get a 4-week supply at one time, one large, rectangular box. Lift up the lid and you'll see each subcutaneous injection is within its own little plastic pouch. I just pop the box in the fridge, then once a week I pull one out, wait 30 minutes to bring it to room temperature and I'm ready to do my injection. I really look forward to getting my BENLYSTA each month. It really is that easy to unpack and put away.

ON-SCREEN TEXT:
BENLYSTA CARES logo
1-877-4-BENLYSTA (1-877-423-6597) Monday to Friday 8 am to 8 pm
Nurses from BENLYSTA Cares do not give medical advice, and will direct you to your healthcare provider for any disease-, treatment-, or referral-related questions.

ON-SCREEN TEXT:
If you have lupus nephritis, one dose may be 2 injections.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
Important Safety Information

NARRATOR:
What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL

What is BENLYSTA?
BENLYSTA is a prescription medicine for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines. It is not known if BENLYSTA is safe and effective in people with severe active central nervous system lupus.

NARRATOR:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. 
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.
Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.
Before receiving BENLYSTA also discuss with your healthcare provider if you:
think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
have or have had mental health problems such as depression or thoughts of suicide.
have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
are allergic to other medicines.
are receiving other biologic medicines or monoclonal antibodies.
have or have had any type of cancer.
have any other medical conditions.
are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least four months after the final dose of BENLYSTA.
Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.
Possible side effects of BENLYSTA
Progressive multifocal leukoencephalopathy (PML).
PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

ON-SCREEN TEXT:
Important Safety Information
Do not receive BENLYSTA if you are allergic to belimumab or to any of the ingredients in BENLYSTA. 
The most important information to know about BENLYSTA
Immunosuppressive agents, including BENLYSTA, can cause serious side effects. Some of these side effects may cause death.

  • Infections: fever, chills, pain or burning with urination, urinating often, coughing up mucus, or warm, red, or painful skin or sores on your body. Infections could be serious, leading to hospitalization or death.
  • Allergic (hypersensitivity) reactions: itching, swelling of the face, lips, mouth, tongue, or throat, trouble breathing, anxiousness, low blood pressure, dizziness or fainting, headache, nausea, or skin rash. Serious allergic reactions can happen on the day of, or in the days after, receiving BENLYSTA and may cause death.
  • Mental health problems and suicide: thoughts of suicide or dying, attempt to commit suicide, trouble sleeping (insomnia), new or worse anxiety or depression, acting on dangerous impulses, other unusual changes in your behavior or mood, or thoughts of hurting yourself or others.
    Before receiving BENLYSTA also discuss with your healthcare provider if you:
  • think you have an infection or have infections that keep coming back. You should not receive BENLYSTA if you have an infection unless your healthcare provider tells you to.
  • have or have had mental health problems such as depression or thoughts of suicide.
  • have recently received a vaccination or if you think you may need a vaccination. If you are receiving BENLYSTA, you should not receive live vaccines.
  • are taking other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
  • are allergic to other medicines.
  • are receiving other biologic medicines or monoclonal antibodies.
  • have or have had any type of cancer.
  • have any other medical conditions.
  • are pregnant or plan to become pregnant. It is not known if BENLYSTA will harm your unborn baby. You should talk to your healthcare provider about whether to prevent pregnancy while on BENLYSTA. If you choose to prevent pregnancy, you should use an effective method of birth control while receiving BENLYSTA and for at least 4 months after the final dose of BENLYSTA.
    Tell your healthcare provider right away if you become pregnant during your treatment with BENLYSTA or if you think you may be pregnant.
  • become pregnant while receiving BENLYSTA. Talk to your healthcare provider about enrolling in the BENLYSTA Pregnancy Registry. You can enroll in this registry by calling 1-877-681-6296. The purpose of this registry is to monitor the health of you and your baby.
  • are breastfeeding or plan to breastfeed. It is not known if BENLYSTA passes into your breast milk. You and your healthcare provider should talk about whether or not you should receive BENLYSTA and breastfeed.

Possible side effects of BENLYSTA

  • Progressive multifocal leukoencephalopathy (PML). PML is a serious and life-threatening brain infection. PML can result in death or severe disability. Tell your healthcare provider right away if you notice any new or worsening medical problems: memory loss, trouble thinking, dizziness or loss of balance, difficulty talking or walking, or loss of vision.
  • Cancer. Medicines that affect the immune system, including BENLYSTA, may increase your risk of certain cancers.

The most common side effects of BENLYSTA are nausea, diarrhea, fever, stuffy or runny nose and sore throat, persistent cough, trouble sleeping, leg or arm pain, depression, headache, and pain, redness, itching, or swelling at the site of injection (when given subcutaneously). These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 

ON-SCREEN TEXT:
BENLYSTA (belimumab)
Intravenous Use 120 mg/vial
Subcutaneous Use 200 mg/mL
For US audiences only.
Trademarks are owned by or licensed to the GSK group of companies.
©2021 GSK or licensor.
BELVID210033 June 2021
Produced in USA.

Working with your doctor

Time with your doctor is valuable, and appointments are great opportunities to get answers. Make the most of your time with these helpful tips and resources.

Img: Doctor with Clipboard
  • Preparing for the appointment

    It’s important to be honest when talking to your doctor. Before your appointment, make a list of symptoms you may be experiencing and gather your medical records. A detailed record helps your doctor get a full picture of what’s been happening with your lupus, and determine the best treatment plan for you.

     

  • Bringing an advocate

    A friend or family member can help you with tasks during your appointment so you can be free to talk to your doctor. Your advocate can act as an extra set of ears or take notes. If you can’t bring a companion into the doctor’s office, don’t worry— just loop them in by phone!

  • How to start the conversation

    This guide will help you feel empowered and be prepared to have productive conversations with your doctor. Use the Let’s Talk guide to prepare for your next appointment. Even if your next visit is a few weeks away, now is the perfect time to get started.

    Placeholder Brochure Image